REAL-WORLD COMPARISON OF HEALTH CARE UTILIZATION BETWEEN DULOXETINE INITIATORS AND PREGABALIN INITIATORS AMONG FIBROMYALGIA PATIENTS

被引：0
|
作者：
Peng, X. [1 ]
Sun, P. [2 ]
Wu, A. [3 ]
Andrews, J. S. [1 ]
Novick, D. [4 ]
Faries, D. [1 ]
Sun, S. [5 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Kailo Res Grp, Fishers, IN USA
[3] Kailo Res Grp, Los Angeles, CA USA
[4] Eli Lilly & Co, Windlesham, Surrey, England
[5] Kailo Res Grp, Fremont, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1432
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A453 / A454
页数：2
相关论文
共 50 条
  • [21] COMPARISON OF THE MOST COMMON REASONS FOR INPATIENT ADMISSIONS AMONG FIBROMYALGIA PATIENTS ON DULOXETINE VERSUS PREGABALIN
    Zhao, Y.
    Sun, P.
    Sun, S.
    VALUE IN HEALTH, 2011, 14 (07) : A412 - A412
  • [22] Real-world effectiveness of reslizumab in patients with severe eosinophilic asthma - "first initiators" and "switchers"
    Hashimoto, S.
    Kroes, J. A.
    Eger, K.
    Mau-Asam, P.
    Hofstee, H. B.
    Bendien, S. A.
    Braunstahl, G.
    Broeders, M. E.
    Imming, L. M.
    Langeveld, B.
    Maitland-Van der Zee, A. H.
    Oud, K. T.
    Patberg, K. W.
    Smeenk, F. W.
    Romme, E. A.
    Van Bezouw, M. J.
    Van de Ven, M. J.
    Van Veen, A.
    Van Velzen, E.
    Van Veen, I. H.
    Weersink, E. J.
    Ten Brinke, A.
    Sont, J. K.
    Bel, E. H.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers
    Hashimoto, Simone
    Kroes, Johannes A.
    Eger, Katrien A.
    Asam, Pearl F. Mau
    Hofstee, Hendrik B.
    Bendien, Sarah A.
    Braunstahl, Gert Jan
    Broeders, Marielle E. A. C.
    Imming, Leonie M.
    Langeveld, Bas
    Maitland-van der Zee, Anke H.
    Oud, Karen T. M.
    Patberg, Kornelis Wiebe
    Smeenk, Frank W. J. M.
    Romme, Elisabeth A. P. M.
    van Bezouw, Maarten J.
    van de Ven, Marjo J.
    van Veen, Anneke
    van Velzen, Edwin
    van Veen, Ilonka H. P. A. A.
    Weersink, Els J. M.
    Ten Brinke, Anneke
    Sont, Jacob K.
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (08): : 2099 - +
  • [24] COMPARISON OF DOSING PATTERNS BETWEEN FIBROMYALGIA PATIENTS WITH HIGH VERSUS LOW DULOXETINE OR PREGABALIN COMPLIANCE
    Zhao, Y.
    Sun, P.
    Sun, S.
    Wu, A.
    VALUE IN HEALTH, 2010, 13 (07) : A311 - A311
  • [25] ADHERENCE TO DULOXETINE THERAPY AND HEALTH CARE COSTS AMONG PATIENTS WITH FIBROMYALGIA
    Chen, S. Y.
    Boulanger, L.
    Fraser, K.
    Wu, N.
    Zhao, Y.
    VALUE IN HEALTH, 2009, 12 (07) : A376 - A377
  • [26] HEALTH CARE RESOURCE UTILIZATION AND COST AMONG NATALIZUMAB INITIATORS WITH MULTIPLE SCLEROSIS IN THE UNITED STATES
    Bonafede, M. M.
    Johnson, B. H.
    Watson, C.
    VALUE IN HEALTH, 2013, 16 (07) : A621 - A621
  • [27] COMPARING TOP REASONS FOR PRIMARY CARE OR SPECIALTY CARE VISITS AMONG FIBROMYALGIA PATIENTS INITIATED DULOXETINE VERSUS PREGABALIN
    Sun, P.
    Sun, S.
    Zhao, Y.
    VALUE IN HEALTH, 2011, 14 (07) : A412 - A412
  • [28] Real-world treatment patterns and health care utilization in patients with prurigo nodularis
    Huang, Amy H.
    Canner, Joseph K.
    Khanna, Raveena
    Williams, Kyle A.
    Kang, Sewon
    Schmidt, Charles E.
    Kwatra, Shawn
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB78 - AB78
  • [29] REAL-WORLD HEALTH CARE UTILIZATION AND COSTS IN NEWLY DIAGNOSED DEPRESSION PATIENTS BETWEEN 2006 AND 2008
    Schneider, G.
    Roy, A.
    Busner, J.
    Crean, S.
    Lanes, S.
    Dabbous, O. H.
    VALUE IN HEALTH, 2011, 14 (03) : A190 - A190
  • [30] Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
    Bedenbaugh, Angela, V
    Bonafede, Machaon
    Marchlewicz, Elizabeth H.
    Lee, Vinson
    Tambiah, Jeyanesh
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 421 - 435
12345